Collaborative Drug Discovery NPS

Collaborative Drug Discovery's Net Promoter Score (NPS) is a 80 with 85% Promoters, 10% Passives, and 5% Detractors. Net Promoter Score tracks whether Collaborative Drug Discovery's customers would recommend using the product based on a scale of -100 to 100.

Collaborative Drug Discovery Overall NPS

80

NPS

85%	Promoters
10%	Passives
5%	Detractors

Collaborative Drug Discovery NPS Trend

-100

-50

0

50

100

Summary	Date	Score
Aug 2020 80	Aug 2020	80

What is NPS

Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"

Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.